Minimally Invasive Surgery Market By Product Type (Surgical Devices, Monitoring & Visualization Systems, Laparoscopy Devices, Endosurgical Equipment, Electrosurgical Equipment), By Service Type (Laparoscopic Surgery, Robotic Surgery), By Technology (Transcatheter Surgery, Laparoscopy Surgery, Non-Visual Imaging, Medical Robotics), By Application (Gastrointestinal Surgery, Gynecology Surgery, Urology Surgery, Bariatric Surgery, Breast Surgery, Cardiac Surgery, Others), and By End User (Hospital Surgical Departments, Outpatient Surgery Centers, Group Practices, Individual Surgeons, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025 – 2035.

---

What trends will shape the Minimally Invasive Surgery Market in the coming years?

The Minimally Invasive Surgery Market accounted for USD 32.45 Billion in 2024 and USD 35.91 Billion in 2025 is expected to reach USD 98.78 Billion by 2035, growing at a CAGR of around 10.65% between 2025 and 2035. There are a few key trends that are bound to drive the Minimally Invasive Surgery (MIS) Market over the next few years. Surgical precision will be improved and the risks of surgical procedures will be minimized through the rapid development of robotic-assisted surgery and AI-assisted surgical planning. The increasing use of laparoscopic and endoscopic surgeries in all specialties is increasing demand. Hospital strategies are being impacted by an increase in patient preference towards a shorter recovery period and minimally invasive procedures.

Real-time imaging and visualization systems are enhancing the results of surgery. Expanding outpatient surgical centers and tele-surgery facilities is helping to support accessibility. The volumes of procedures are being driven by an increased number of chronic diseases and aging. There are also more innovations in surgical procedures and electrosurgical devices that will likely lead to a further increase in the market.

What do industry experts say about the Minimally Invasive Surgery market trends?

“We are pleased by customer adoption of da Vinci 5, and the core measures of our business remain healthy.”

• Gary S. Guthart, Former CEO, Intuitive Surgical.

“We are at an exciting time with a significant opportunity to advance the work that customers care most about, the Quintuple Aim, improving patient outcomes, enhancing patient and care team experience, expanding patient access to care, and ultimately lowering the total cost to treat.”

• Dave Rosa, CEO of Intuitive Surgical.

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Minimally Invasive Surgery market?

How does increasing demand for outpatient procedures boost minimally invasive surgery adoption?

The growing popularity of outpatient procedures as a more characteristic trend in the sphere of modern healthcare is having a strong impact on the minimally invasive surgery market. The U.S. Agency of Healthcare Research and Quality notes that over 60% of all surgical operations are currently conducted in the outpatient environment, which is a significant change in care delivery. The highly minimally invasive methods, which enable shorter incisions, less pain, and less recovery time, favor this move as same-day discharge becomes a possibility. This is useful to hospitals and ambulatory surgery centers because faster turnover of patients enhances resource utilization.

Outpatient MIS procedures are also safer and more affordable than inpatient procedures by helping reduce the chances of infection and lowering the overall treatment cost. These methods are also promoted by insurers who give incentives to cost-saving models. Furthermore, outpatient centers are also incorporating the use of new technology, such as robotic-assisted and laparoscopic, which has enhanced access. This has enabled device manufacturers to design devices that meet outpatient processes. The trio of patient focus, clinical effectiveness, and cost motivation is increasing uptake at a global pace. Finally, increased dependence on outpatient surgery is solidifying MIS as the modality of choice in several specialties.

Why do technological innovations in surgical robotics enhance accuracy and patient treatment outcomes?

Minimally Invasive Surgery Market Rapid technological advances in surgical robotics are transforming the minimally invasive surgery market and are having a direct impact on improving both accuracy and treatment outcomes. According to the U.S. National Library of Medicine, complex operations have a robot-assisted surgery accuracy of over 95% and also prove the reliability of surgery robots. Surgical systems give surgeons greater dexterity with tremor filtration, scaled instrument motion, and magnified 3D images so delicate structures can be treated more carefully. These features reduce the chances of surgery error, loss of blood, and complications relative to traditional procedures. Patients experience less hospitalization, faster recovery, and less pain after the surgery, which increases satisfaction.

Even when the experience of surgeons differs, hospitals report more consistent results across the surgical teams. The most modern robotics can allow access to previously untreatable areas of the body that are now accessible through minimally invasive procedures. This not only enhances patient safety but also increases operating room efficiency and workflow. These benefits are also embraced by insurers and health practitioners, which further helps to adopt them. In total, surgical robotics is reinventing the standard of precision, safety, and effectiveness in minimally invasive surgery across the globe.

How do high equipment costs limit accessibility for healthcare providers adopting advanced systems?

One of the biggest limitations of the minimally invasive surgery market is that high equipment prices restrict access to many healthcare providers. Robot surgical systems, laparoscopic towers, and high-tech visualization devices can be multimillion-dollar investments and cannot be afforded by smaller hospitals and outpatient facilities. Besides the purchase expenses, providers also incur maintenance and software update costs, as well as disposable equipment costs. Surgeon and operating personnel training on these advanced systems also increases cost. These costs are prohibitive to many health care facilities, particularly in the developing world, despite the obvious clinical advantages.

Hospital-constrained budgets encourage hospitals to focus more on basic services as compared to the integration of advanced technology. This makes the distribution of minimally invasive care unequal because urban centers have access, and rural communities are sidelined. Smaller practices have a hard time competing with large hospitals that are able to afford such systems, even in more affluent nations. Expensive products also reduce the speed of replacement cycles, which slows the release of more recent and safer products. Finally, another limitation to pervasive application and equal access to healthcare markets is the financial barrier of advanced MIS systems.

How can the integration of artificial intelligence revolutionize surgical planning and intraoperative decision-making?

The adoption of artificial intelligence is disrupting the minimally invasive surgery market by revolutionizing both the way surgery is planned and the way it is done in hospitals around the globe. This is why the U.S. National Institutes of Health reports that the number of diagnostic mistakes is down by as much as one out of three with the help of AI-assisted technologies, which merely confirms its usefulness in the narrow context of improving clinical accuracy. Surgical planning can be a fast process because AI can process patient-specific data and help surgeons design the best possible strategies and foresee risks even before surgical operations.

Within the operating room, AI-based image recognition helps locate the key anatomical features with a high degree of accuracy to reduce possible complications. These systems are also capable of providing dynamic intraoperative changes with real-time alerts and suggestions. Predictive analytics can also support decision-making by predicting reactions of patients to increase trust where the overall operation is high stakes. The result of this human expertise and machine intelligence is minimized tissue damage, less time spent on the procedure, and enhanced safety. Also, the use of AI simplifies surgery processes, reduces outcome variability, and helps provide consistent care. AI is strengthening confidence in minimally invasive methods by increasing accuracy and flexibility. Finally, it is framing more sophisticated technologies as essential to better treatment outcomes and more personalized care.

Why will expanding medical tourism create growth prospects for minimally invasive treatment adoption?

Medical tourism is rapidly growing and currently poses a great market opportunity to the minimally invasive surgery market, as more and more patients are opting to receive affordable and quality care in other countries than their own. The U.S. Centers for Disease Control and Prevention states that millions of Americans seek medical treatment abroad every year and save hundreds of thousands of dollars in expenses relative to care at home. Of particular interest in this regard are minimally invasive procedures that have shorter recovery times, less pain, and fewer hospital stays, which are easier and safer to travel to. Asian and Latin American countries have established themselves to be the world leaders in terms of providing skilled surgeons, high-tech equipment, and affordable prices. Patients do not undergo treatment procedures, such as bariatric surgery, cosmetic surgery, orthopedics, and so on, and these are also the least invasive.

The faster recovery to work makes these surgeries more attractive to meet the demands of patients across the globe. Medical tourism-oriented governments are also making large investments in infrastructure to cater to this need. Overseas minimally invasive procedures are gaining in acceptance, and insurance companies are beginning to accept overseas procedures. In addition, hospital accreditation by countries has also increased trust and confidence among patients. This combination of low cost, technology, and accessibility is a guarantee that medical tourism will continue to increase the use of minimally invasive procedures worldwide.

What are the key market segments in the Minimally Invasive Surgery industry?

Based on the product type, the Minimally Invasive Surgery Market is classified into Surgical Devices, Monitoring & Visualization Systems, Laparoscopy Devices, Endosurgical Equipment, and Electrosurgical Equipment. Surgical devices are the backbone of operations and enable accuracy and a reduced level of invasiveness. Watching and observation systems can provide real-time images and instructions that enhance the accuracy and safety of the surgical operation and the patient. Laparoscopy devices are mostly used in abdominal and pelvic surgeries with minimal scarring and a quick recovery.

Endosurgical equipment helps with the high-end interventions in complicated surgeries with small cuts and flexible tools. The electrosurgical equipment plays a significant role in controlling bleeding, cutting, and efficiency in the processes. Collectively, these product categories allow safer, quicker, and more efficient surgical procedures. They are slowly gaining popularity as more and more people are demanding minimally invasive procedures. This segmentation shows the way in which technological development continues to influence the development of the market.

Based on the application, the Minimally Invasive Surgery Market is classified into Gastrointestinal Surgery, Gynecology Surgery, Urology Surgery, Bariatric Surgery, Breast Surgery, Cardiac Surgery, and Others. Gastrointestinal surgery is a significant percentage of the increasing number of digestive disorders. Gynecology surgery is expanding fast due to the demand for the least invasive treatment of women. Urology surgery is an innovative laparoscopic and robot-assisted treatment of kidney, bladder, and prostate diseases.

Bariatric surgery is becoming popular as the world faces the rising weight problem. Breast surgery applications deal with both cosmetic and oncological interventions that result in minimal scarring. Catheter-based and robotic-assisted procedures are changing how cardiac surgery is performed, shortening the recovery period. The other segment is a wide range of new applications in a variety of specialties. The combination of these applications explains why MIS is playing an increasingly significant role in enhancing the performance of many medical fields.

Which regions are leading the Minimally Invasive Surgery market, and why?

The North America Minimally Invasive Surgery Market is leading due to well-developed healthcare facilities and the early adoption of new technology. The geographic area has a good representation of the major players, high research and development, and a good regulatory environment towards device approvals. Minimally invasive procedures are in demand due to the increased prevalence of chronic diseases like cardiovascular disorders, obesity, and cancer.

Increased investments in robotic-assisted systems and technologies in imaging are also helping to enhance the precision of surgery. There is a rapid growth in MIS capabilities in hospitals and outpatient surgery centers in the U.S. and Canada. Adoption is being reinforced by increasing the preference of patients to have shorter hospital stays and a quicker recovery. Favorable reimbursement activities and government interventions also lead to the growth of the market. Generally, North America will continue to lead during the forecast period, as the region is projected to experience continued innovation and growth in demand.

The Asia Pacific Minimally Invasive Surgery Market is growing due to the increasing healthcare spending and growing hospital facilities. The rapid urbanization process and the continually growing middle-class population are driving increased demand for highly specialized solutions. The increasing number of lifestyle diseases like obesity, diabetes, and cardiovascular diseases is enhancing the use of MIS procedures. Medical technology integration and modernization of healthcare are being encouraged by governments in countries such as China, India, and Japan.

Robotic and laparoscopic approaches are steadily being embraced by surgeons throughout the region in an effort to achieve better results. It is also being heavily influenced by medical tourism, where patients are looking to get inexpensive but high-quality treatment and surgery. Global and regional investments are increasing the pace of access to new devices and training. As the news of quicker healing and fewer complications spreads, the Asia-Pacific will probably have the highest growth percentage over the next few years.

What does the competitive landscape of the Minimally Invasive Surgery market look like?

The global Minimally Invasive Surgery Market leaders who influence the competitive environment of the minimally invasive surgery market include Intuitive Surgical, Medtronic, Johnson & Johnson (Ethicon), Stryker, Boston Scientific, Zimmer Biomet, Olympus, Smith & Nephew, KARL STORZ, and B. Braun Melsungen. These are businesses that are interested in innovation, mergers, and partnerships to strengthen their market presence. Intuitive Surgical has the largest share of robotic-assisted procedures, and Medtronic and Johnson & Johnson have the largest number of products in their device portfolio.

Stryker and Zimmer Biomet are focused on orthopedic and robotic technologies, and Olympus is developing imaging technologies. Bosch Scientific and CONMED are the leaders in endoscopic and electrosurgical technologies. The world is a very competitive market, and companies invest in AI, robotics, and visualization tools to be competitive. Another emerging trend in the Asia-Pacific region is the proliferation of regional players in order to seize untapped opportunities. A major step in this direction came in July 2025, when Zimmer Biomet acquired Monogram Technologies and its robotics business, expanding its robotics offerings and establishing itself as a provider of autonomous surgery technologies. Taken together, all these dynamics point to the high competition and faster innovation that define the global MIS scene.

Minimally Invasive Surgery Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Minimally Invasive Surgery industry?

• In July 2025, Zimmer Biomet announced the acquisition of Monogram Technologies for approximately $177 million, aimed at bolstering its autonomous robotics portfolio. The acquisition includes FDA-cleared semi-autonomous knee replacement tech and plans to launch fully autonomous surgical robots.
• In July 2025, King George's Medical University (KGMU) in Lucknow began construction for a new hybrid operating theatre, a state-of-the-art facility costing Rs 18 crore, which will serve as a dedicated space for interventional radiology procedures. This "pin-hole" surgery facility will offer minimally invasive treatments for a range of conditions, including cancer, heart problems, and vascular diseases, utilizing advanced technology for precise interventions through small incisions.
• In March 2025, Fujifilm Corporation announced the commercial launch of its EN-840T Double Balloon Enteroscopy (DBE) scope, offering comprehensive diagnostic and therapeutic access to the entire small intestine

Report Coverage:

By Product Type

• Surgical Devices
• Monitoring & Visualization Systems
• Laparoscopy Devices
• Endosurgical Equipment
• Electrosurgical Equipment

By Service Type

• Laparoscopic Surgery
• Robotic Surgery

By Technology

• Transcatheter Surgery
• Laparoscopy Surgery
• Non-Visual Imaging
• Medical Robotics

By Application

• Gastrointestinal Surgery
• Gynecology Surgery
• Urology Surgery
• Bariatric Surgery
• Breast Surgery
• Cardiac Surgery
• Others

By End User

• Hospital Surgical Departments
• Outpatient Surgery Centers
• Group Practices
• Individual Surgeons
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Intuitive Surgical, Inc.
• Medtronic plc
• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Boston Scientific Corporation
• Smith & Nephew plc
• Olympus Corporation
• KARL STORZ SE & Co. KG
• B. Braun Melsungen AG
• CONMED Corporation
• Cook Medical Incorporated
• FUJIFILM Holdings Corporation
• Applied Medical Resources Corporation
• HOYA Corporation

Frequently Asked Questions (FAQs)